Abstract
Hepatocellular carcinoma (HCC) remains one of the most common and aggressive human cancers worldwide. Accumulating evidences indicate that non-coding RNAs are critical regulators implicated in various physiological processes including HCC development. Long non-coding RNA (lncRNA) MYCN opposite-strand (MYCNOS) was reported to be up-regulated in several human cancers, yet its role in HCC progression is still elusive. In the present study, MYCNOS was up-regulated in both HCC tissues and cell lines, and elevated MYCNOS expression was correlated to shorter survival time of HCC patients. We knocked down MYCNOS expression using short hairpin RNAs specifically targeting MYCNOS. MYCNOS knockdown significantly inhibited proliferation in HCC cells in vitro accompanied by exacerbated cell apoptosis; it also suppressed tumor growth in mouse model in vivo. Besides, the migration and invasion of HCC cells were remarkably inhibited after MYCNOS knockdown. In addition, MYCNOS acted as a negative regulator of miR-340 in HCC cells, and all effects of MYCNOS knockdown were abrogated by further miR-340 inhibition. We also discovered that oncogene phosphatidylinositol-3, 4, 5-trisphosphate-dependent Rac exchange factor 2 (PREX2) was a downstream target of miR-340, and PREX2 expression was positively correlated to that of MYCNOS in HCC tissues. In conclusion, our findings demonstrated that MYCNOS knockdown inhibited HCC progression through regulating miR-340.
Similar content being viewed by others
Availability of data and materials
All data generated or analyzed during this study are included in this published article.
References
EASL-EORTC Clinical Practice Guidelines. EASL-EORTC clinical practice guidelines management of hepatocellular carcinoma. Eur J Cancer. 2012;48(5):599–641. https://doi.org/10.1016/j.ejca.2011.12.021.
Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer. 2006;118(12):3030–44. https://doi.org/10.1002/ijc.21731.
Okita K. Hepatocellular carcinoma. Nihon Naika Gakkai Zasshi. 2002;91(2):627–32.
Roberts LR, Gores GJ. Hepatocellular carcinoma: molecular pathways and new therapeutic targets. Semin Liver Dis. 2005;25(2):212–25. https://doi.org/10.1055/s-2005-871200.
Iizuka N, Oka M, Yamada-Okabe H, Mori N, Tamesa T, Okada T, et al. Differential gene expression in distinct virologic types of hepatocellular carcinoma: association with liver cirrhosis. Oncogene. 2003;22(19):3007–14. https://doi.org/10.1038/sj.onc.1206401.
Zhou S, Wang J, Zhang Z. An emerging understanding of long noncoding RNAs in kidney cancer. J Cancer Res Clin Oncol. 2014;140(12):1989–95. https://doi.org/10.1007/s00432-014-1699-y.
Martens-Uzunova ES, Bottcher R, Croce CM, Jenster G, Visakorpi T, Calin GA. Long noncoding RNA in prostate, bladder, and kidney cancer. Eur Urol. 2014;65(6):1140–51. https://doi.org/10.1016/j.eururo.2013.12.003.
O’Brien EM, Selfe JL, Martins AS, Walters ZS, Shipley JM. The long non-coding RNA MYCNOS-01 regulates MYCN protein levels and affects growth of MYCN-amplified rhabdomyosarcoma and neuroblastoma cells. BMC Cancer. 2018;18(1):217. https://doi.org/10.1186/s12885-018-4129-8.
Zhao X, Li D, Pu J, Mei H, Yang D, Xiang X, et al. CTCF cooperates with noncoding RNA MYCNOS to promote neuroblastoma progression through facilitating MYCN expression. Oncogene. 2016;35(27):3565–76. https://doi.org/10.1038/onc.2015.422.
Vadie N, Saayman S, Lenox A, Ackley A, Clemson M, Burdach J, et al. MYCNOS functions as an antisense RNA regulating MYCN. RNA Biol. 2015;12(8):893–9. https://doi.org/10.1080/15476286.2015.1063773.
Su Y, Qiu Y, Qiu Z, Qu P. MicroRNA networks regulate the differentiation, expansion and suppression function of myeloid-derived suppressor cells in tumor microenvironment. J Cancer. 2019;10(18):4350–6. https://doi.org/10.7150/jca.35205.
Shirmohamadi M, Eghbali E, Najjary S, Mokhtarzadeh A, Kojabad AB, Hajiasgharzadeh K, et al. Regulatory mechanisms of microRNAs in colorectal cancer and colorectal cancer stem cells. J Cell Physiol. 2019. https://doi.org/10.1002/jcp.29042.
Wu ZS, Wu Q, Wang CQ, Wang XN, Huang J, Zhao JJ, et al. MiR-340 inhibition of breast cancer cell migration and invasion through targeting of oncoprotein c-Met. Cancer. 2011;117(13):2842–52. https://doi.org/10.1002/cncr.25860.
Zhou X, Wei M, Wang W. MicroRNA-340 suppresses osteosarcoma tumor growth and metastasis by directly targeting ROCK1. Biochem Biophys Res Commun. 2013;437(4):653–8. https://doi.org/10.1016/j.bbrc.2013.07.033.
Fernandez S, Risolino M, Mandia N, Talotta F, Soini Y, Incoronato M, et al. MiR-340 inhibits tumor cell proliferation and induces apoptosis by targeting multiple negative regulators of p27 in non-small cell lung cancer. Oncogene. 2015;34(25):3240–50. https://doi.org/10.1038/onc.2014.267.
Wilusz JE, Sunwoo H, Spector DL. Long noncoding RNAs: functional surprises from the RNA world. Genes Dev. 2009;23(13):1494–504. https://doi.org/10.1101/gad.1800909.
Shi X, Sun M, Liu H, Yao Y, Song Y. Long non-coding RNAs: a new frontier in the study of human diseases. Cancer Lett. 2013;339(2):159–66. https://doi.org/10.1016/j.canlet.2013.06.013.
Qiu MT, Hu JW, Yin R, Xu L. Long noncoding RNA: an emerging paradigm of cancer research. Tumour Biol. 2013;34(2):613–20. https://doi.org/10.1007/s13277-013-0658-6.
Wapinski O, Chang HY. Long noncoding RNAs and human disease. Trends Cell Biol. 2011;21(6):354–61. https://doi.org/10.1016/j.tcb.2011.04.001.
Jacobs JF, van Bokhoven H, van Leeuwen FN, Hulsbergen-van de Kaa CA, de Vries IJ, Adema GJ, et al. Regulation of MYCN expression in human neuroblastoma cells. BMC Cancer. 2009;9:239. https://doi.org/10.1186/1471-2407-9-239.
Long J, Bai Y, Yang X, Lin J, Wang D, He L, et al. Construction and comprehensive analysis of a ceRNA network to reveal potential prognostic biomarkers for hepatocellular carcinoma. Cancer Cell Int. 2019;19:90. https://doi.org/10.1186/s12935-019-0817-y.
Liu B, Ma T, Li Q, Wang S, Sun W, Li W, et al. Identification of a lncRNA-associated competing endogenous RNA-regulated network in clear cell renal cell carcinoma. Mol Med Rep. 2019;20(1):485–94. https://doi.org/10.3892/mmr.2019.10290.
Feitelson MA, Arzumanyan A, Kulathinal RJ, Blain SW, Holcombe RF, Mahajna J, et al. Sustained proliferation in cancer: mechanisms and novel therapeutic targets. Semin Cancer Biol. 2015;35(Suppl):S25–54. https://doi.org/10.1016/j.semcancer.2015.02.006.
Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell. 2011;146(3):353–8. https://doi.org/10.1016/j.cell.2011.07.014.
Yuan J, Ji H, Xiao F, Lin Z, Zhao X, Wang Z, et al. MicroRNA-340 inhibits the proliferation and invasion of hepatocellular carcinoma cells by targeting JAK1. Biochem Biophys Res Commun. 2017;483(1):578–84. https://doi.org/10.1016/j.bbrc.2016.12.102.
Li CH, Yen CH, Chen YF, Lee KJ, Fang CC, Zhang X, et al. Characterization of the GNMT-HectH9-PREX2 tripartite relationship in the pathogenesis of hepatocellular carcinoma. Int J Cancer. 2017;140(10):2284–97. https://doi.org/10.1002/ijc.30652.
Lan X, Xiao F, Ding Q, Liu J, Li J, Zhang J, et al. The effect of CXCL9 on the invasion ability of hepatocellular carcinoma through up-regulation of PREX2. J Mol Histol. 2014;45(6):689–96. https://doi.org/10.1007/s10735-014-9593-0.
Funding
Not applicable.
Author information
Authors and Affiliations
Contributions
JFY, ZJO, and KSZ conceived and designed the experiments. YYL and LHC analyzed and interpreted the results of the experiments. QS performed the experiments.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests, and all authors should confirm its accuracy.
Ethics approval and consent to participate
The animal use protocol listed below has been reviewed and approved by the Animal Ethical and Welfare Committee.
Informed consent
Written informed consent was obtained from a legally authorized representative(s) for anonymized patient information to be published in this article.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Yu, J., Ou, Z., Lei, Y. et al. LncRNA MYCNOS facilitates proliferation and invasion in hepatocellular carcinoma by regulating miR-340. Human Cell 33, 148–158 (2020). https://doi.org/10.1007/s13577-019-00303-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13577-019-00303-y